FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to methods of prolongation of the orgasm period in a patient, who requires it, as well as to a method of treating premature ejaculation by the local introduction to the patient of clostridial neurotoxin such as butulinum neurotoxin.
EFFECT: group of inventions represents a long-term, non-systemic method of treating premature ejaculation and/or prolongation of the orgasm time, which does not require per oral or repeated introduction of a pharmaceutical composition before sexual intercourse.
16 cl, 4 ex
